NINA KEOWN: Open Payments
NPI 1316299662 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,822 in 70 payments from 14 companies in 2025. Trend: 2023 $1,510 · 2024 $2,146 · 2025 $1,822
Food & beverage: $1,677Education: $145
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $328 |
| Janssen Biotech, Inc. | 8 | $325 |
| Amgen Inc. | 10 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $148 |
| Lilly USA, LLC | 7 | $128 |
| UCB, Inc. | 6 | $125 |
| PFIZER INC. | 5 | $113 |
| Organogenesis Inc. | 4 | $102 |
| LEO Pharma Inc. | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
Products named: TREMFYA, SKYRIZI, OTEZLA, TALTZ, Bimzelx, DUPIXENT, AFFINITY, CIBINQO.
Industry payments across GA — which companies pay providers there.
